Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination
The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · 1329-1336
DOI: 10.1093/infdis/jiae241 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 14.05.2024. Verfasst von Boitumelo M Motsoeneng und 6 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, So…. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Collaborative Influenza Vaccine Innovation, University of the Witwatersrand, South Africa.
Abstract (Originalsprache)
Background
Future vaccine candidates aim to elicit antibodies against the conserved hemagglutinin stalk domain. Understanding the protective mechanism of these antibodies, which mediate broad neutralization and Fc-mediated functions, following seasonal vaccination is critical.
Methods
Plasma samples were obtained from pregnant women with or without HIV-1 enrolled in a randomised trial (138 trivalent inactivated vaccine [TIV] and 145 placebo recipients). Twenty-three influenza cases were confirmed within 6 months postpartum. We measured H1 stalk-specific antibody-dependent cellular phagocytosis (ADCP), complement deposition (ADCD) and cellular cytotoxicity (ADCC) at enrolment and 1-month postvaccination.
Results
Lower H1 stalk-specific ADCP and ADCD activity was detected for participants with confirmed influenza compared with individuals without illness 1-month postvaccination. Pre-existing ADCP scores ≥250 reduced the odds of A/H1N1 infection (odds ratio [OR], 0.11; P = .01) with an 83% likelihood of risk reduction. Following TIV, ADCD scores of ≥25 and ≥15 significantly reduced the odds against A/H1N1 (OR, 0.10; P = .01) and non-group 1 (OR, 0.06; P = .0004) influenza virus infections, respectively. These ADCD scores were associated with >84% likelihood of risk reduction.
Conclusions
Overall, H1 stalk-specific Fc effector function correlates with protection against influenza illness following influenza vaccination during pregnancy. These findings provide insight into the protective mechanisms of hemagglutinin stalk antibodies. Clinical Trials Registration NCT01306669 and NCT01306682 (ClinicalTrials.gov).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- South African Medical Research Council Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- HIV Virology Section, Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
- South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Science and Innovation/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,…
- Center of Excellence in Respiratory Pathogens, Hospices Civils de Lyon and Centre International de Recherche en Infectiologie, Équipe Santé Publique, Épidémiologie et Écologie Évolutive des Maladies Infectieuses (PHE3ID…
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Florian Krammer, Simone I Richardson
Förderung
- Collaborative Influenza Vaccine Innovation
- University of the Witwatersrand
- South Africa
- Poliomyelitis Research Foundation
- Department of Science and Innovation
- Department of Science and Technology
- National Research Foundation, South Africa
- NIAID NIH HHS
Zitieren
APA
Motsoeneng, B. M., Dhar, N., Nunes, M. C., Krammer, F., Madhi, S. A., Moore, P. L., & Richardson, S. I. (2024). Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination. The Journal of Infectious Diseases, 230(6), 1329-1336. https://doi.org/10.1093/infdis/jiae241
Vancouver
Motsoeneng BM, Dhar N, Nunes MC, Krammer F, Madhi SA, Moore PL, et al. Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination. The Journal of Infectious Diseases. 2024;230(6):1329-1336. doi:10.1093/infdis/jiae241
BibTeX
@article{Motsoeneng2024,
author = {Motsoeneng, Boitumelo M and Dhar, Nisha and Nunes, Marta C and Krammer, Florian and Madhi, Shabir A and Moore, Penny L and Richardson, Simone I},
title = {Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {6},
pages = {1329--1336},
doi = {10.1093/infdis/jiae241}
}
EUVIMED